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AbstrAct:   oncoplastic and reconstructive techniques are essential tools in the armamentarium of contemporary breast surgeons. The aim 
of the study was to identify oncoplastic reconstructive patterns in breast cancer centers across Poland. A questionnaire of 18 ques-
tions was sent by email to the members of the Polish Society of Surgical oncology and the Polish Society of Plastic, Reconstructive 
and Esthetic Surgery via their dedicated websites. The numbers of breast cancer patients operated on in each center ranged from 
120 to 904 per year. Breast conserving surgery (BCS) predominated in all but one center (range 50-70%). immediate breast re-
constructions (iBR) accounted for 6-42% of procedures, The most frequent type of iBR was either a two-stage expander followed 
by a permanent implant or one-stage implant- based with or without synthetic mesh. The most frequent type of delayed breast 
reconstruction (dBR) was a two- stage expander followed by implant- based reconstruction. None of the surveyed cancer centers 
performed free flap reconstruction. deep inferior epigastric perforator (diEP) flaps were performed in the plastic surgery depart-
ment. Reconstructions based on pedicled flaps were performed in cancer centers. Acellular dermal matrices (AdM) and fat trans-
fer were used in selected centers. in the clinical scenario of adjuvant radiotherapy, delayed breast reconstruction was favored. The 
full range of oncoplastic BCS was performed. Patient-reported outcome measures (PRoM) and complications were assessed. our 
findings can act as a platform for further improvement in skills, certification, data collection and audit, including patient report-
ed expectation measures. There is also an urgent need to address pan-European inconsistencies in procedural reimbursement.
Keywords:  breast cancer, oncoplastic surgery, patient reported outcomes
IntroductIon
Oncoplastic and reconstructive techniques are essential tools in the arma-
mentarium of contemporary breast surgeons. They are particularly useful 
in patients with larger or multifocal tumors who wish to preserve their bre-
ast by cosmesis, in patients with down-sized tumors following neoadjuvant 
chemotherapy, and in mastectomized patients who wish to have breast re-
construction [1-4]. Oncoplastic breast surgery was established in the 1990s 
and has been flourishing in recent years [5, 6]. However, many differences 
remain in the quality of breast cancer surgery across the various geographi-
cal areas of Europe [7]. In many countries there is still no formal training 
and structured curriculum in breast oncoplastic surgery [8]. Though many 
surgeons are technically able to do implants, this needs to be carried out 
within a multidisciplinary setting, to establish and agree on the appropriate 
treatment on a sound oncological basis [7]. Currently, data on Polish breast 
surgical practice in Poland is limited. There is a real need for benchmarking. 
AIm
The aim of the study was to identify oncoplastic reconstructive 
patterns in breast cancer centers across Poland.
mAterIAls And methods
A questionnaire of 18 questions was sent by email to the members of 
the Polish Society of Surgical Oncology and the Polish Society of Pla-
stic, Reconstructive and Esthetic Surgery via their dedicated websites.
results
Breast surgeons from 7 of 14 cancer centers and 1 of 10 plastic 
surgery departments completed the questionnaire.
The numbers of breast cancer patients operated on in each center 
ranged from 120 to 904 per year. In all cancer centers a variety of 
oncoplastic/ reconstructive, immediate and delayed techniques 
were performed. In the single plastic surgery center that respon-
ded, only delayed reconstructions were performed, as it was not 
within the structure of a cancer institute. Of the seven cancer cen-
ters, oncoplastic or reconstructive techniques were performed so-
lely by a surgical oncologist in five, and by a surgical oncologist or 
in collaboration with a plastic surgeon in two. In the single plastic 
surgery department, reconstructions were performed by a plastic 
surgeon independently. Breast conserving surgery (BCS) predo-
minated in all but one center (range 50-70%). A further center 
performed only 24% BCS.
Immediate breast reconstructions (IBR) accounted for 6-42% of 
procedures, depending on the center. The most frequent type of 
IBR was either a two-stage expander followed by a permanent im-
plant or one-stage implant- based with or without synthetic mesh. 
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should actually be involved may be under dispute and this needs 
to be addressed nationally [12].
This study shows that in the majority of centers surgical oncologists 
with oncoplastic skills carried out oncoplastic and reconstructive 
surgery. This might be due to some plastic surgery departments 
operating in isolation from cancer centers, thus limiting them to 
delayed reconstruction only. Surgical breast oncoplastic surgeons 
in Poland are now able to offer a broad spectrum of techniques, 
skills acquired by specialist training and attachments in high-pro-
file international breast units and attendance at courses endorsed 
for example by the European Society of Surgical Oncology, and 
American or European Societies of Plastic Surgery. 
In Poland, there is an urgent need for closer collaboration betwe-
en surgical oncologists, general and plastic surgeons. A dedica-
ted plastic surgeon with a special interest in breast reconstruction 
should be a part of every multidisciplinary team to ensure optimal 
initial evaluation of all breast cancer patients.
The most common type of IBR in Poland was found to be implant- 
based breast reconstruction. This figure is in line with UK figures 
given in the Second Annual Report of the National Mastectomy and 
Breast Reconstruction Audit (NMBRA). The prevalence of IBR in 
the UK was 38% in 2007, rising to 54% in 2014.  The most frequent 
type of DBR procedure in the UK was free flap breast reconstruc-
tion, rising from 25% to 42% between 2007 and 2014 (range from 
23% to 74% across region) [13]. In contrast, despite introduction 
of microsurgical flaps for breast reconstruction in Poland in 1996 
(Witwicki et al.), the country lags behind. This has been attributed 
to the extensive learning curve in comparison with implant- ba-
sed breast reconstruction and insufficient reimbursement by the 
National Health Fund [14]. 
In Poland approximately 50 free TRAM, DIEP and SIEA breast 
reconstructions are performed annually, and probably double 
that number in 2017 [15]. In contrast, in Germany, the annual 
number of free flaps for breast reconstruction is about 1200, in-
cluding 200 in Duesseldorf, where reimbursement is more gene-
rous (unilateral DIEP – 14,200 euro, bilateral DIEP- 18,500 euro, 
free TRAM- 9800 euro and pedicled TRAM- 7500 euro) (Andree, 
personal communication). A lack of standardized reimbursement 
for oncoplastic techniques across Europe, may well be one of the 
key reasons behind the difference in the number of free flap re-
constructions between Western and Eastern Europe, which can 
be as great as 14 times.
The questionnaire also examined the optimum timing and form of 
breast reconstruction for the clinical scenario of postmastectomy 
radiotherapy. Cordeiro et al. prospectively found that the preva-
lence of severe capsular contracture grade 4 was 12-fold higher in 
irradiated versus non-irradiated patients (7.4% versus 0.6%, respec-
tively) and implant loss 13-fold higher (9.1% versus 0.7%), but still 
70% of irradiated women had good to excellent aesthetic results, 
and 95% would choose implants again [16]. Our findings indicate 
that when radiotherapy was planned, delayed reconstruction of 
the breast with autologous tissue e.g. LD plus implant, TRAM or 
DIEP if available, or fat transfer were performed and in determi-
ned patients implant- based breast reconstruction with disclosure 
of higher complication rates. In the latter cohort implant radia-
tion was preferred by the majority of breast surgeons. This is in 
The most frequent type of delayed breast reconstruction (DBR) was 
a two- stage expander followed by implant- based reconstruction. 
None of the surveyed cancer centers performed free flap recon-
struction. Deep inferior epigastric perforator (DIEP) flaps were 
performed in the plastic surgery department. 
Reconstructions based on pedicled flaps, such as latissimus dorsi 
(LD) or transverse rectus abdominis muscle (TRAM) were per-
formed in cancer centers. Acellular dermal matrices (ADM) were 
used in only one of the seven cancer centers. Fat harvesting and 
transfer was performed in 4 cancer centers and in the plastic sur-
gery department.
 In the clinical scenario of adjuvant radiotherapy planned after 
surgery, delayed breast reconstruction was favored or in very de-
termined patients-  immediate implant- based reconstruction, to-
gether with counselling about the risk of increased complications.
 In 5 of 7 cancer centers, breast reconstructions were carried out 
after neoadjuvant chemotherapy. Patient-reported outcome me-
asures (PROM) were assessed by a subjective scale, Breast Q qu-
estionnaire, photos or EORTC QoL in 5 of 7 centers. In 3 others 
such measures were planned to be implemented. 
Complications after expander/ implant- based breast reconstruc-
tions occurred in 3-6% patients (hematoma, infection, seroma, im-
plant loss, extrusion, transposition). No data was available relating 
to capsular contracture. 
In all cancer centers, the full range of oncoplastic BCS was perfor-
med (mammaplasties- vertical, inverted T, dermoglandular flaps, 
round block, etc). According to surgeons participated in our stu-
dy, availability of breast surgeons was insufficient in 4 of 7 cancer 
centers and in one of the plastic surgery departments. 
Reimbursement of oncoplastic and reconstructive procedures by 
the National Health Fund was insufficient in all cancer and plastic 
surgery centers. Departments received 4843 Polish zloty for free 
flap breast reconstruction (1 euro=4.4 zloty), no reimbursement 
for adjusting contralateral breast symmetry, ADM and lipofilling, 
and there was no differentiation in reimbursement between clas-
sic BCS and the more sophisticated and time-consuming oncopla-
stic BCS. Reimbursement for bilateral procedures was inadequate. 
Data are shown in Table 1.
dIscussIon
Breast surgeons need to deliver safe, affordable and timely surgery, 
including oncoplastic reshaping or reconstruction of the breast to 
all breast cancer patients [9]. This has a profound impact both on 
survival and femininity [10]. 
The majority of hospitals participating in this survey were high-vo-
lume centers treating at least 150 newly- diagnosed primary breast 
cancer patients, the minimum requirement for designation as a 
specialist breast center by the European Society of Breast Cancer 
Specialist (EUSOMA guidelines) [11].  Across Europe oncoplastic 
reconstruction is performed by specialist breast, general or pla-
stic surgeons, sometimes in collaboration with each other; who 
WWW.PPCH.PL14
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characteristics of the women treated [19]. In Ukraine there were 
marked discrepancies between private and public institutions. 
In the private sector in Kiev, 52% of patients had immediate bre-
ast reconstruction, and the full range of oncoplastic techniques 
is offered [21].  
In conclusion, there is a need for certified breast units and stan-
dardized oncoplastic techniques performed by specialist onco-
plastic breast surgeons across Europe. Variation is more marked 
between level I and level II oncoplastic procedures and implant 
vs. flap- based breast reconstruction. However, there is an ongo-
ing expansion in oncoplastic reconstruction, in terms of numbers 
performed, variety and complexity of techniques. For example the-
re has been a 6-fold increase with low complication rates in some 
Eastern European countries over the last decade. 
European breast surgeons are eager to improve their skills, as evi-
denced by fully or overbooked ESSO-endorsed breast surgery cour-
ses and other high quality workshops. Applications for the Europe-
an Examination in Breast Surgery (EBSQBS) continue to increase.
Available data is inevitably biased due to the absence of a dedica-
ted oncoplastic registry in Poland as in most European countries, 
incomplete or skewed data from individual surgeons or centers. 
However, our findings can act as a platform for further improve-
ment in skills, certification, data collection and audit, including 
patient reported outcomes and expectation measures. There is 
also an urgent need to address pan-European inconsistencies in 
procedural reimbursement.
line with observations made by Cordeiro et al. that there was a 
2-fold increase in predicted failure rates for patients with tis-
sue expander radiation than for patients with permanent im-
plant [17]. Andree et al. described an intriguing IDEAL con-
cept (Immediate implant DElayed AutoLogous) for patients in 
whom radio-chemotherapy is needed, either in a neoadjuvant 
or adjuvant setting [18]. Nipple- sparing mastectomy is perfor-
med by a breast surgeon from the senology department. If the 
patient opts for definitive autologous reconstruction, an im-
mediate implant reconstruction is inserted epipectorally, fol-
lowed by a DIEP flap performed 4-6 months later by a plastic 
surgeon with microsurgical skills. If a patient prefers a defini-
tive implant- based reconstruction, this is carried out using a 
subpectoral approach with synthetic mesh or acellular dermal 
matrix. In capsular contracture or other complications arise, 
the implant is removed and replaced by a flap [18].
Complication rates (3-6%) after implant-based breast reconstruction 
in Poland were comparable with institutions in Western Europe. In 
the UK, for example , the NMBRA database shows a 3% complica-
tion rate (infection requiring antibiotics or removal, displacement 
requiring reposition) [19] and in Spain 5% (infection, extrusion) [20].
The availability of oncoplastic and reconstructive techniques va-
ries across Europe. This questionnaire has shown that in Poland 
there is an insufficient number of breast surgeons.  In the UK in 
2010, immediate breast reconstruction rates varied significantly 
between 9% and 43% across the 30 English Cancer Network and 
this could not be explained by the socio-demographic and clinical 
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